MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/ciz740

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020

Serologic Markers of Previous Malaria Exposure and Functional Antibodies Inhibiting Parasite Growth Are Associated With Parasite Kinetics Following a Plasmodium falciparum Controlled Human Infection.

Achan Jane, Reuling Isaie J, Yap Xi Zen, Dabira Edgard, Ahmad Abdullahi, Cox Momodou, Nwakanma Davis, Tetteh Kevin, Wu Lindsey, Bastiaens Guido J H, Abebe Yonas, Manoj Anita, Kaur Harparkash, Miura Kazutoyo, Long Carole, Billingsley Peter F, Sim B Kim Lee, Hoffman Stephen L, Drakeley Chris, Bousema Teun, D'Alessandro Umberto

СтатьяПоддержка NIH: внешняя программаResearch Support, N.I.H., IntramuralПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

We assessed the impact of exposure to Plasmodium falciparum on parasite kinetics, clinical symptoms, and functional immunity after controlled human malaria infection (CHMI) in 2 cohorts with different levels of previous malarial exposure.

METHODS

Nine adult males with high (sero-high) and 10 with low (sero-low) previous exposure received 3200 P. falciparum sporozoites (PfSPZ) of PfSPZ Challenge by direct venous inoculation and were followed for 35 days for parasitemia by thick blood smear (TBS) and quantitative polymerase chain reaction. Endpoints were time to parasitemia, adverse events, and immune responses.

RESULTS

Ten of 10 (100%) volunteers in the sero-low and 7 of 9 (77.8%) in the sero-high group developed parasitemia detected by TBS in the first 28 days (P = .125). The median time to parasitemia was significantly shorter in the sero-low group than the sero-high group (9 days [interquartile range {IQR} 7.5-11.0] vs 11.0 days [IQR 7.5-18.0], respectively; log-rank test, P = .005). Antibody recognition of sporozoites was significantly higher in the sero-high (median, 17.93 [IQR 12.95-24] arbitrary units [AU]) than the sero-low volunteers (median, 10.54 [IQR, 8.36-12.12] AU) (P = .006). Growth inhibitory activity was significantly higher in the sero-high (median, 21.8% [IQR, 8.15%-29.65%]) than in the sero-low group (median, 8.3% [IQR, 5.6%-10.23%]) (P = .025).

CONCLUSIONS

CHMI was safe and well tolerated in this population. Individuals with serological evidence of higher malaria exposure were able to better control infection and had higher parasite growth inhibitory activity.

CLINICAL TRIALS REGISTRATION: NCT03496454.

Для цитирования: Achan Jane, Reuling Isaie J, Yap Xi Zen, Dabira Edgard, Ahmad Abdullahi, Cox Momodou, Nwakanma Davis, Tetteh Kevin, Wu Lindsey, Bastiaens Guido J H, Abebe Yonas, Manoj Anita, Kaur Harparkash, Miura Kazutoyo, Long Carole, Billingsley Peter F, Sim B Kim Lee, Hoffman Stephen L, Drakeley Chris, Bousema Teun, D'Alessandro Umberto. Serologic Markers of Previous Malaria Exposure and Functional Antibodies Inhibiting Parasite Growth Are Associated With Parasite Kinetics Following a Plasmodium falciparum Controlled Human Infection.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020. DOI: 10.1093/cid/ciz740.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.